Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0410
-0.0010 (-2.38%)
Sep 11, 2026, 9:59 AM AEST
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 66.94 million as of September 10, 2026. Its market cap has increased by 49.96% in one year.
Market Cap
66.94M
Enterprise Value
61.36M
Revenue
1.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 66.94M, an increase of 75.86%. That is a compound annual growth rate of 28.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 66.94M | 30.05% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 110.34M |
| Recce Pharmaceuticals | 108.55M |
| Avecho Biotechnology | 88.87M |
| LTR Pharma | 84.53M |
| Arovella Therapeutics | 72.53M |
| Prescient Therapeutics | 68.35M |
| Neurizon Therapeutics | 65.88M |
| Immutep | 64.84M |